Publication | Closed Access
A phase II study of REOLYSIN® (pelareorep) in combination with carboplatin and paclitaxel for patients with advanced malignant melanoma
88
Citations
24
References
2017
Year
MedicineMelanomaPharmacologyPathologyPhase Ii StudyAdvanced Malignant MelanomaCancer TreatmentOncologyRadiation OncologyCancer ResearchMolecular Oncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1